Patents by Inventor Thomas J. Scarlata

Thomas J. Scarlata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
    Publication number: 20230346715
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Application
    Filed: June 30, 2023
    Publication date: November 2, 2023
    Applicant: NEXZOL PHARMA, INC.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • Transdermal formulation for the treatment of pain and/or inflammation
    Patent number: 11723880
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: August 15, 2023
    Assignee: NEXZOL PHARMA, INC.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • TRANSDERMAL FORMULATIONS
    Publication number: 20220110860
    Abstract: Described herein are transdermal formulations and methods of using the same.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Applicant: NEXZOL PHARMA, INC.
    Inventors: Joseph M. FRACASSI, Thomas J. SCARLATA
  • TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
    Publication number: 20210401770
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Application
    Filed: September 9, 2021
    Publication date: December 30, 2021
    Applicant: NEXZOL PHARMA, INC.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • Transdermal formulation for the treatment of pain and/or inflammation
    Patent number: 11116730
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: September 14, 2021
    Assignee: NexZol Pharma, Inc.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
    Publication number: 20200405660
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Application
    Filed: March 13, 2020
    Publication date: December 31, 2020
    Applicant: NEXZOL PHARMA, INC.
    Inventors: Joseph M. FRACASSI, Thomas J. SCARLATA
  • Transdermal formulation for the treatment of pain and/or inflammation
    Patent number: 10588871
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: March 17, 2020
    Assignee: NEXZOL PHARMA, INC.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • Convertible closure for a container
    Patent number: 8141729
    Abstract: Convertible closure for a container includes an outer closure member having a first child-resistant portion on an inner surface, a first inner closure member having an inner surface arranged to engage with a neck of the container and a second child-resistant portion arranged to selectively engage with the first child-resistant portion on the outer closure member, and a second inner closure member arranged to engage with both the outer closure member and the first inner closure member. The selective engagement of the first and second child-resistant portion is designed so that when engaged, the closure has a non-child resistant configuration (only grasping and rotation of the outer closure member is sufficient to twist the closure out of engagement with the container) and when not engaged therewith, the closure has a child-resistant configuration (grasping, rotation and downward pressure is required to remove the closure from engagement with the container).
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: March 27, 2012
    Assignee: The Thomas J. & Kathleen Scarlata Living Trust
    Inventor: Thomas J. Scarlata
  • CONVERTIBLE CLOSURE FOR A CONTAINER
    Publication number: 20090120896
    Abstract: Convertible closure for a container includes an outer closure member having a first child-resistant portion on an inner surface, a first inner closure member having an inner surface arranged to engage with a neck of the container and a second child-resistant portion arranged to selectively engage with the first child-resistant portion on the outer closure member, and a second inner closure member arranged to engage with both the outer closure member and the first inner closure member. The selective engagement of the first and second child-resistant portion is designed so that when engaged, the closure has a non-child resistant configuration (only grasping and rotation of the outer closure member is sufficient to twist the closure out of engagement with the container) and when not engaged therewith, the closure has a child-resistant configuration (grasping, rotation and downward pressure is required to remove the closure from engagement with the container).
    Type: Application
    Filed: November 12, 2008
    Publication date: May 14, 2009
    Applicant: GOLD PASSAGE INC.
    Inventor: Thomas J. SCARLATA